EUVIMEDEUVIMED entdecken
Crossref

Metabolic and Hormonal Profile of Insulin-Like Peptide 5 (INSL5) in Polycystic Ovary Syndrome: A Prospective Analysis

Deniz Cengiz iD, Esra Nur Ademoğlu Dilekçi, Ömür Albayrak, Özgür Mehmet Yis

Hormone and Metabolic Research · 01.07.2025 · 57 (07) · 416-422

DOI: 10.1055/a-2636-9491 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.07.2025. Verfasst von Deniz Cengiz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Bolu Abant İzzet Baysal University, Bolu, Turkey. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Abant Izzet Baysal Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder with diverse metabolic and hormonal manifestations. Insulin-like peptide 5 (INSL5), a gut-derived hormone of the relaxin/insulin family, is expressed in the central nervous system, colonic and reproductive tissues, but its clinical significance in PCOS remains unclear. This study aimed to evaluate circulating INSL5 levels in PCOS and explore their associations with key hormonal and metabolic parameters. In this prospective cross-sectional study, 45 women with newly diagnosed PCOS and 35 age-matched healthy controls (18–35 years) were evaluated. Clinical characteristics, hormonal profiles, and metabolic markers – including serum anti-Müllerian hormone (AMH) and INSL5 – were assessed. INSL5 levels were measured using enzyme-linked immunosorbent assay (ELISA). Median serum INSL5 levels did not differ significantly between PCOS and control groups (12.5 vs. 15.5 ng/ml; p=0.103). However, within the PCOS group, INSL5 was inversely correlated with body mass index, insulin, HOMA-IR, total and LDL cholesterol, triglycerides, fat mass, and free androgen index, and positively correlated with sex hormone-binding globulin (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeHumansFemaleAdultProspective StudiesYoung AdultCross-Sectional StudiesAdolescentInsulinCase-Control StudiesBiomarkersInsulin ResistanceAnti-Mullerian Hormone

Substanzen

InsulinBiomarkersAnti-Mullerian Hormone

Autor:innen und Institutionen

  • Internal Medicine, Bolu Abant İzzet Baysal University, Bolu, Turkey.
  • Senior Health, St George's University Hospitals NHS Foundation Trust, London, United Kingdom of Great Britain and Northern Ireland.
  • Endocrinology and Metabolic Diseases, Bolu Abant İzzet Baysal University, Bolu, Turkey.
  • Obstetrics and Gynecology, Bolu Abant İzzet Baysal University, Bolu, Turkey.
  • Biochemistry, Bolu Abant İzzet Baysal University, Bolu, Turkey.

ORCID-Profile: Deniz Cengiz

Förderung

  • Abant Izzet Baysal Üniversitesi

Zitieren

APA

Cengiz, D., Ademoğlu Dilekçi, E. N., Albayrak, Ö., & Yis, Ö. M. (2025). Metabolic and Hormonal Profile of Insulin-Like Peptide 5 (INSL5) in Polycystic Ovary Syndrome: A Prospective Analysis. Hormone and Metabolic Research, 57(07), 416-422. https://doi.org/10.1055/a-2636-9491

Vancouver

Cengiz D, Ademoğlu Dilekçi EN, Albayrak Ö, Yis ÖM. Metabolic and Hormonal Profile of Insulin-Like Peptide 5 (INSL5) in Polycystic Ovary Syndrome: A Prospective Analysis. Hormone and Metabolic Research. 2025;57(07):416-422. doi:10.1055/a-2636-9491

BibTeX
@article{Cengiz2025,
  author = {Cengiz, Deniz and Ademoğlu Dilekçi, Esra Nur and Albayrak, Ömür and Yis, Özgür Mehmet},
  title = {Metabolic and Hormonal Profile of Insulin-Like Peptide 5 (INSL5) in Polycystic Ovary Syndrome: A Prospective Analysis},
  journal = {Hormone and Metabolic Research},
  year = {2025},
  volume = {57},
  number = {07},
  pages = {416--422},
  doi = {10.1055/a-2636-9491}
}
Kostenlos starten →